Both in Biotechnology
MeiraGTx Holdings vs Ginkgo Bioworks Holdings
Over the past year MGTX returned +4.5% and DNA returned −13.7%; their daily moves had a correlation of 0.26.
MGTX +4.5% DNA −13.7%Growth of $1, one year, split-adjusted
| Metric | MGTX | DNA |
|---|---|---|
| Price | $9.49 | $11.21 |
| Market cap | $911.4M | $754.9M |
| Today | −2.22% | −12.01% |
| 1 month | −11.0% | −10.3% |
| 6 months | +0.9% | +15.6% |
| Year to date | +19.4% | +34.9% |
| 1 year | +6.3% | −8.0% |
| Revenue growth (YoY) | +8608.6% | −48.5% |
| Gross margin | 97.8% | 91.5% |
| Net margin | 50.0% | −231.7% |
| P/E (TTM) | 11.5× | — |
| Price / sales | 2.3× | 6.7× |
| Net cash | $21.8M | $302.2M |
| Dividend yield | — | — |
| Volatility (60d) | 47.5% | 125.2% |
| Short % of float | 10.8% | 18.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).